Hong Kong (HQ)ShanghaiZurichChicago
HKG time - 14:32 HKTLinkedIncontact@visionlifesciences.com
About the firm

A partner-led practice for cross-border life sciences.

Partner-led. Selective. Local presence across three continents. One integrated team, by appointment.

Arrange a private introduction →orRead our principles
Partner-owned · IndependentThree continents · One teamSelective mandates · No outside capital
ModelPartner-LedSenior attention from first call
ReachThree ContinentsHKG · SHA · ZRH · CHI
Deal ExperienceMulti-DecadeCross-border mandates from sourcing to signing
OwnershipPartner-OwnedNo outside financial sponsors
The thesis
The best science is being developed across borders. So are the partnerships that matter.
House viewThe firm — Hong Kong
How we work

Three principles, without exception.

Not unusual on paper. Unusual in practice.

/ 01Principle 01 of 03

Partner-led, end to end

The principal who signs the mandate runs it through close. No mid-deal handoffs, no associate-only readouts.

  • One accountable partner
  • Weekly principal touchpoint
  • Continuity through close
In practice
/ 02Principle 02 of 03

Selective, by design

We work a small number of mandates at a time. We decline more than we accept. Conflicts are written, not whispered.

  • Written conflict screening
  • Information barriers
  • Fewer, deeper engagements
In practice
/ 03Principle 03 of 03

Discretion as the service

We do not market deals. We do not name counterparties without consent. The work shows up in our clients’ results.

  • NDA-first conversations
  • No league-tables
  • No house deal-flow
In practice
ChicagoAmericas
ZurichEurope
ShanghaiGreater China
Hong KongAsia-Pacific
Footprint

One firm. Three continents.

Senior coverage across each region. Same partners on every mandate. Not a network — one phone tree.

Asia-Pacific
Hong Kong
Local time
--:--HKG
Greater China
Shanghai
Local time
--:--SHA
Europe
Zurich
Local time
--:--ZRH
Americas
Chicago
Local time
--:--CHI
A short history

Built for cross-border life-science work.

2018 · Origin

Hong Kong

Practice opened by partners with global pharma BD and Greater China biotech backgrounds.

2019 — 2021 · Cross-border reach

Shanghai · Zurich

Mainland China and EU coverage deepened. First multi-jurisdiction NewCo formation closed.

2022 — 2023 · Coverage

Modalities · Americas

Cell & gene, ADC, and bispecific coverage formalized. Americas coverage added.

2024 — Today

Publications · Scale

Dragon Pipeline and BioDeal Weekly launched. A growing portfolio of executed cross-border mandates.

Begin

The first conversation is quiet.

Arrange a private introduction →RESPONSE WITHIN 24 HOURS · NDA-FIRST